buy only 94.5Buy only above 94.5
T1: 101.5
T2:------------ 121.5
T3-------------------- 135
STOPLOSS:------------------------- 86.25
−8.37USD
−506.98 MUSD
249.38 MUSD
59.80 M
About Blueprint Medicines Corporation
Sector
Industry
CEO
Kathryn Haviland
Website
Headquarters
Cambridge
Employees (FY)
655
Founded
2008
ISIN
US09627Y1091
FIGI
BBG001MC8YF7
Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BPMC is 85.18 USD — it has decreased by 2.37% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Blueprint Medicines Corporation stocks are traded under the ticker BPMC.
Blueprint Medicines Corporation is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Blueprint Medicines Corporation has a max estimate of 125.00 USD and a min estimate of 50.00 USD.
BPMC earnings for the last quarter are −2.20 USD whereas the estimation was −2.37 USD which accounts for 7.07% surprise. Estimated earnings for the next quarter are −2.04 USD. See more details about Blueprint Medicines Corporation earnings.
Blueprint Medicines Corporation revenue for the last quarter amounts to 56.60 M USD despite the estimated figure of 50.66 M USD. In the next quarter revenue is expected to reach 67.12 M USD.
Yes, you can track Blueprint Medicines Corporation financials in yearly and quarterly reports right on TradingView.
Like other stocks, BPMC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Blueprint Medicines Corporation stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 655.00 employees. See our rating of the largest employees — is Blueprint Medicines Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Blueprint Medicines Corporation EBITDA is −467.85 M USD, and current EBITDA margin is −190.32%. See more stats in Blueprint Medicines Corporation financial statements.